This places the receptor phenotypes of the MINAS breast cancers intermediate between that of BRCA2 only and BRCA1 only breast cancers, and would be consistent with an independent rather than synergistic effect in BRCA1/BRCA2 MINAS. The gene discussed is BRCA1; the disease is breast cancer.